Stability Indicating RP-HPLC Method for Bosentan in Tablet Dosage form
DOI:
https://doi.org/10.7439/ijbar.v8i10.4456Abstract
A simple, precise and reproducible stability indicating HPLC method has been developed and validated for determination Bosentan on an Intersil ODS column (250*4.6*5um) using a mobile phase consisting of Disodium phosphate Buffer and acetonitrile (30:70) at flow 1.0 ml/min. Detection was carried out at 273nm . The method was validated with respect to specificity, accuracy linearity, precession, ruggedness and robustness parameters as per ICH guidelines. Linearity of the method was found to be 0.999; %RSD of precession was below 2.0%, recovery of added drug within 98-102 %, System suitability parameters were within limit for Bosentan. The Degradation study was performed during different stress conditions in stability studies. The results obtained in this research work are indicated that the developed method is simple, accurate and precise, sensitive and applicable for analysis in commercially available formulation sample.Downloads
References
https://en.wikipedia.org/wiki/Bosentan. 2. https://www.drugs.com/cdi/bosentan.html. 3. http://reference.medscape.com/drug/tracleer-bosentan-342395 4. Annapurna MM, Bisht SPS, Kumar BVVR, Kumar VR, Narendra A. Spectrophotometric determination of bosentan and its application in pharmaceutical analysis. Int. J. Comp. Pharma. 2011; 2 (1): 1-2 5. Ashok Kumar A, Anil Kumar A, Sankar DG. Development, estimation and validation of bosentan in bulk and in its pharmaceutical formulation by UV-VIS spectroscopic method. Int. J. Pharma. Bio. Sci.2011; 2(2): 225-230. 6. Kumar D, Sreenivas SA, Samal HB, Dey S, Priyanka Y. Method development and estimation of bosentan monohydrate in bulk and pharmaceutical dosage forms using UV-Visible spectrophotometer. J. Pharma. Res. 2011; 4(6): 1713-1715. 7. Narendra A, Deepika D, Annapurna MM. New spectrophotometric method for the determination ofbosentan - An anti-hypertensive agent in pharmaceutical dosage forms. E-J. Chem. 2012; 9(2): 700-704. 8. Jadhav SA, Landge SB, Jadhav SL, Niphade NC, Bembalkar SR, Mathad VT. Stability-indicating gradient RP-LC method for the determination of process and degradation impurities in Bosentan monohydrate: An endothelin receptor antagonist. Chromatogr. Res. Int. 2011; 2011(ID 929876): 1-5. 9. Lausecker B, Hess B,Fischer G, Mueller M, Hopfgartner G. Simultaneous determination of Bosentan and its three major metabolites in various biological matrices and species using narrow bore liquid chromatography with ion spray tandem mass spectrometric detection.J.Chromatogr. B. Biomed. Sci.Appl.2000; 749(1):67-83. 10. Khan MA, Sinha S, Todkar M, Parashar V, Swamy K. Development and validation of a stability indicating analytical method for the related substances of bosentan drug substance by HPLC. AmericanJ. Sci. Ind. Res. 2012; 3(2): 69-80. 11. International Conference on Harmonization, "Q2A: Text on Validation of Analytical Procedures," Federal Register,1995.
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).
How to Cite
